Gaucher disease diagnosed after bone marrow trephine biopsy - a report of two cases

Folia Histochemica et Cytobiologica

Volumn 49, Issue 2, 2011, Pages 352-356

  Sokolowska, Bozena ^a   Skomra, Danuta ^a   Czartoryska, Barbara ^b   Tomczak, Waldemar ^a   Tylki Szymańska, Anna ^c   Gromek, Tomasz ^a   Dmoszyńska, Anna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Gaucher disease; Hepatosplenomegaly; Trephine biopsy

Indexed keywords

BILIRUBIN; CHITOTRIOSIDASE; CYANOCOBALAMIN; IMIGLUCERASE; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; ANEMIA; ARTICLE; BILIRUBIN BLOOD LEVEL; BONE MARROW BIOPSY; CASE REPORT; CHOLECYSTECTOMY; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DENSITOMETRY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; ECCHYMOSIS; ECHOGRAPHY; ENZYME BLOOD LEVEL; FATIGUE; GALLSTONE; GAUCHER DISEASE; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; HYPERMENORRHEA; LABORATORY TEST; LEG PAIN; LIVER BIOPSY; MALE; OSTEOPENIA; SKIN DISCOLORATION; THROMBOCYTOPENIA; WEAKNESS; BIOPSY; BONE MARROW; FEMALE; METABOLISM; PATHOLOGY;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOPSY; BONE MARROW; FEMALE; GAUCHER DISEASE; HUMANS; MALE;

EID: 80055109275     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2011.0048     Document Type: Article

References (12)

1. Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Beaudet AL, Valle D, Sly WS (eds). The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York, NY: McGraw-Hill. 2001;3635-3668.
2. Grabowski GA. Lysosomal storage diseases. In: Braunwald E, Fauci AS (eds). Harrison's Principles of Internal Medicine, 15th ed. New York, NY: McGraw-Hill. 2001; 2276-2281.
3. Zimran A, Altarescu G, Rudensky G, Abrahamov A, Elstein D. Survey of hematological aspects of Gaucher disease. Hematology. 2005;10:151-156.
4. Lachmann RH, Wight DG, Lomas DJ et al. Massive hepatic fibrosis in Gaucher's disease: Clinico-pathological and radiological features. QJM. 2000;93:237-244.
5. Cox TM, Schofield JP. Gaucher's disease: Clinical features and natural history. Baillieres Clin Haematol. 1997;10:657-689.
6. Mistry PK, Sirrs S, Chan A et al. Pulmonary hypertension in type I Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy. Mol Genet Metab. 2002;77:91-98.
7. Wenstrup RJ, Roca-Espiau M, Wienreb NJ, Bembi B. Skeletal aspects of Gaucher disease: a review. Br J Radiol. 2002;75(Suppl.1):A2-A12.
8. Pastores GM, Weinreb NJ, Aerts H et al. Therapeutic goals in the treatment of Gaucher disease. Semin Hematol. 2004;41(Suppl.5):4-14.
9. Mistry PK, Sadan S, Yang R, Yee J, Yang M. Consequences of diagnostic delays in type I Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention. Am. J. Hematol. 2007;82:697-701.
10. Halsall DJ, Kriegshauser G, Moritz A, Elsey TS, Oberkanins C. Rapid genetic testing for Gaucher disease by reverse hybridization. Ann Clin Biochem. 2003;40:419-421.
11. Boot RG, Verhoek M, de Fost M, Hollak CE, Maas M, Bleijlevens B. Marked elevation of the chemokine CCL18//PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood. 2004;103:33-39.
12. Sokolowska B, Skomra D, Czartoryska B et al. Chitotriosidase as a marker of treatment regularity: a case report. Fifth International Symposium on Lysosomal Storage Disorders. Paris, France - April 10-12, 2008. Gaucher disease p 22.